Diazaborine is an antibacterial drug that inhibits enoyl-ACP reductase in Escherichia coli. Diazaborine treatment of yeast inhibits processing of the rRNA precursors for the large ribosomal subunit.
ChEBI: Diazaborine is a organonitrogen heterocyclic compound consisting of 2,3,1-benzodiazaborinine substituted at positions 1 and 2 by hydroxy and 4-toluenesufonyl groups respectively. It has a role as a geroprotector. It is an organoboron compound, an organonitrogen heterocyclic compound and a sulfonamide.
Cell permeable: yes', 'Primary Target
Drg1 AAA-ATPase', 'Reversible: yes
